{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:35:44Z","timestamp":1782448544838,"version":"3.54.5"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12016-019-08760-x","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T17:02:38Z","timestamp":1564419758000},"page":"160-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Asthma Phenotypes as a Guide for Current and Future Biologic Therapies"],"prefix":"10.1007","volume":"59","author":[{"given":"Daniel","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7553-9751","authenticated-orcid":false,"given":"Heather","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"9537","key":"8760_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","volume":"368","author":"SE Wenzel","year":"2006","unstructured":"Wenzel SE (2006) Asthma: defining of the persistent adult phenotypes. Lancet 368(9537):804\u2013813. https:\/\/doi.org\/10.1016\/S0140-6736(06)69290-8","journal-title":"Lancet"},{"issue":"2","key":"8760_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","volume":"127","author":"J Lotvall","year":"2011","unstructured":"Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA (2011) Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127(2):355\u2013360. https:\/\/doi.org\/10.1016\/j.jaci.2010.11.037","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8760_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","volume":"10","author":"CM Lloyd","year":"2010","unstructured":"Lloyd CM, Hessel EM (2010) Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol 10(12):838\u2013848. https:\/\/doi.org\/10.1038\/nri2870","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8760_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy JV (2015) Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol 15(1):57\u201365. https:\/\/doi.org\/10.1038\/nri3786","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"8760_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cea.12880","volume":"47","author":"D Robinson","year":"2017","unstructured":"Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, Hanania NA, Nair P (2017) Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy 47(2):161\u2013175. https:\/\/doi.org\/10.1111\/cea.12880","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"8760_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2567.2011.03499.x","volume":"134","author":"CJ Oliphant","year":"2011","unstructured":"Oliphant CJ, Barlow JL, McKenzie AN (2011) Insights into the initiation of type 2 immune responses. Immunology 134(4):378\u2013385. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03499.x","journal-title":"Immunology"},{"issue":"4","key":"8760_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1573395510666140304235916","volume":"9","author":"S Lund","year":"2013","unstructured":"Lund S, Walford HH, Doherty TA (2013) Type 2 innate lymphoid cells in allergic disease. Curr Immunol Rev 9(4):214\u2013221. https:\/\/doi.org\/10.2174\/1573395510666140304235916","journal-title":"Curr Immunol Rev"},{"issue":"4","key":"8760_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1067\/mai.2003.1333","volume":"111","author":"GK Hershey","year":"2003","unstructured":"Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111(4):677\u2013690 quiz 691","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"8760_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1067\/mai.2000.107604","volume":"105","author":"H Jiang","year":"2000","unstructured":"Jiang H, Harris MB, Rothman P (2000) IL-4\/IL-13 signaling beyond JAK\/STAT. J Allergy Clin Immunol 105(6 Pt 1):1063\u20131070","journal-title":"J Allergy Clin Immunol"},{"key":"8760_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/JAA.S39119","volume":"7","author":"HH Walford","year":"2014","unstructured":"Walford HH, Doherty TA (2014) Diagnosis and management of eosinophilic asthma: a US perspective. J Asthma Allergy 7:53\u201365. https:\/\/doi.org\/10.2147\/JAA.S39119","journal-title":"J Asthma Allergy"},{"issue":"10","key":"8760_CR11","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.4049\/jimmunol.154.10.5061","volume":"154","author":"J Louahed","year":"1995","unstructured":"Louahed J, Kermouni A, Van Snick J, Renauld JC (1995) IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol 154(10):5061\u20135070","journal-title":"J Immunol"},{"issue":"2","key":"8760_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/rr42","volume":"2","author":"Y Zhou","year":"2001","unstructured":"Zhou Y, McLane M, Levitt RC (2001) Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma. Respir Res 2(2):80\u201384","journal-title":"Respir Res"},{"issue":"1","key":"8760_CR13","doi-asserted-by":"publisher","first-page":"00024","DOI":"10.1183\/23120541.00024-2015","volume":"1","author":"JC de Groot","year":"2015","unstructured":"de Groot JC, Ten Brinke A, Bel EH (2015) Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res 1(1):00024\u201302015. https:\/\/doi.org\/10.1183\/23120541.00024-2015","journal-title":"ERJ Open Res"},{"issue":"1","key":"8760_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-065X.2011.01032.x","volume":"242","author":"NR Bhakta","year":"2011","unstructured":"Bhakta NR, Woodruff PG (2011) Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev 242(1):220\u2013232. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01032.x","journal-title":"Immunol Rev"},{"issue":"2","key":"8760_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaci.2004.10.046","volume":"115","author":"J Cui","year":"2005","unstructured":"Cui J, Pazdziorko S, Miyashiro JS, Thakker P, Pelker JW, Declercq C, Jiao A, Gunn J, Mason L, Leonard JP, Williams CM, Marusic S (2005) TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation. J Allergy Clin Immunol 115(2):309\u2013315. https:\/\/doi.org\/10.1016\/j.jaci.2004.10.046","journal-title":"J Allergy Clin Immunol"},{"issue":"37","key":"8760_CR16","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.0706378104","volume":"104","author":"N Hayashi","year":"2007","unstructured":"Hayashi N, Yoshimoto T, Izuhara K, Matsui K, Tanaka T, Nakanishi K (2007) T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc Natl Acad Sci U S A 104(37):14765\u201314770. https:\/\/doi.org\/10.1073\/pnas.0706378104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"8760_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18(5):716\u2013725. https:\/\/doi.org\/10.1038\/nm.2678","journal-title":"Nat Med"},{"issue":"1","key":"8760_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11882-009-0081-7","volume":"10","author":"DK Agrawal","year":"2010","unstructured":"Agrawal DK, Shao Z (2010) Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep 10(1):39\u201348. https:\/\/doi.org\/10.1007\/s11882-009-0081-7","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"8760_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3349\/ymj.2010.51.6.797","volume":"51","author":"S Reuter","year":"2010","unstructured":"Reuter S, Stassen M, Taube C (2010) Mast cells in allergic asthma and beyond. Yonsei Med J 51(6):797\u2013807. https:\/\/doi.org\/10.3349\/ymj.2010.51.6.797","journal-title":"Yonsei Med J"},{"issue":"5 Pt 1","key":"8760_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1164\/ajrccm.152.5.7582283","volume":"152","author":"B Burrows","year":"1995","unstructured":"Burrows B, Martinez FD, Cline MG, Lebowitz MD (1995) The relationship between parental and children's serum IgE and asthma. Am J Respir Crit Care Med 152(5 Pt 1):1497\u20131500. https:\/\/doi.org\/10.1164\/ajrccm.152.5.7582283","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8760_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/02770909809071000","volume":"35","author":"PE Silkoff","year":"1998","unstructured":"Silkoff PE, McClean PA, Slutsky AS, Caramori M, Chapman KR, Gutierrez C, Zamel N (1998) Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 35(6):473\u2013479","journal-title":"J Asthma"},{"issue":"8","key":"8760_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","volume":"187","author":"NA Hanania","year":"2013","unstructured":"Hanania NA, Wenzel S, Rosen K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W (2013) Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 187(8):804\u2013811. https:\/\/doi.org\/10.1164\/rccm.201208-1414OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"8760_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1517\/14712598.2014.859673","volume":"14","author":"S Agrawal","year":"2014","unstructured":"Agrawal S, Townley RG (2014) Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4\/IL-13 antagonist in asthma. Expert Opin Biol Ther 14(2):165\u2013181. https:\/\/doi.org\/10.1517\/14712598.2014.859673","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"8760_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jaci.2016.03.009","volume":"137","author":"A Berry","year":"2016","unstructured":"Berry A, Busse WW (2016) Biomarkers in asthmatic patients: has their time come to direct treatment? J Allergy Clin Immunol 137(5):1317\u20131324. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.009","journal-title":"J Allergy Clin Immunol"},{"key":"8760_CR25","doi-asserted-by":"publisher","unstructured":"National Asthma E, Prevention P (2007) Expert panel report 3 (EPR-3): guidelines for the diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 120 (5 Suppl):S94\u2013138. doi: https:\/\/doi.org\/10.1016\/j.jaci.2007.09.043","DOI":"10.1016\/j.jaci.2007.09.043"},{"issue":"3","key":"8760_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","volume":"60","author":"M Humbert","year":"2005","unstructured":"Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K (2005) Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60(3):309\u2013316. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00772.x","journal-title":"Allergy"},{"issue":"1","key":"8760_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","volume":"142","author":"SF Weinstein","year":"2018","unstructured":"Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A (2018) Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol 142(1):171\u2013177 e171. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.051","journal-title":"J Allergy Clin Immunol"},{"issue":"22","key":"8760_CR28","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","volume":"370","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR (2014) Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 370(22):2102\u20132110. https:\/\/doi.org\/10.1056\/NEJMoa1402895","journal-title":"N Engl J Med"},{"key":"8760_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2147\/DDDT.S147389","volume":"12","author":"ED Bateman","year":"2018","unstructured":"Bateman ED, O'Brien C, Rugman P, Luke S, Ivanov S, Uddin M (2018) Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting beta2-agonists in patients with atopic asthma. Drug Des Devel Ther 12:1093\u20131106. https:\/\/doi.org\/10.2147\/DDDT.S147389","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"8760_CR30","doi-asserted-by":"publisher","first-page":"1700670","DOI":"10.1183\/13993003.00670-2017","volume":"50","author":"ED Bateman","year":"2017","unstructured":"Bateman ED, Guerreros AG, Brockhaus F, Holzhauer B, Pethe A, Kay RA, Townley RG (2017) Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids. Eur Respir J 50(2):1700670. https:\/\/doi.org\/10.1183\/13993003.00670-2017","journal-title":"Eur Respir J"},{"key":"8760_CR31","doi-asserted-by":"publisher","first-page":"843763","DOI":"10.1155\/2011\/843763","volume":"2011","author":"AP Knutsen","year":"2011","unstructured":"Knutsen AP, Slavin RG (2011) Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011:843763\u2013843713. https:\/\/doi.org\/10.1155\/2011\/843763","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"8760_CR32","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jaip.2017.06.024","volume":"5","author":"P Giavina-Bianchi","year":"2017","unstructured":"Giavina-Bianchi P, Kalil J (2017) Diagnosis of allergic bronchopulmonary aspergillosis exacerbations. J Allergy Clin Immunol Pract 5(6):1599\u20131600. https:\/\/doi.org\/10.1016\/j.jaip.2017.06.024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6 Pt 1","key":"8760_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1067\/mai.2000.106210","volume":"105","author":"HF Kauffman","year":"2000","unstructured":"Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P (2000) Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105(6 Pt 1):1185\u20131193","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8760_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0091-6749(94)90257-7","volume":"93","author":"JF Tomee","year":"1994","unstructured":"Tomee JF, Kauffman HF, Klimp AH, de Monchy JG, Koeter GH, Dubois AE (1994) Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases. J Allergy Clin Immunol 93(4):768\u2013778","journal-title":"J Allergy Clin Immunol"},{"issue":"6776","key":"8760_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/35006097","volume":"404","author":"L Gu","year":"2000","unstructured":"Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404(6776):407\u2013411. https:\/\/doi.org\/10.1038\/35006097","journal-title":"Nature"},{"issue":"1","key":"8760_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/myc.12541","volume":"60","author":"R Agarwal","year":"2017","unstructured":"Agarwal R, Dua D, Choudhary H, Aggarwal AN, Sehgal IS, Dhooria S, Garg M, Behera D, Chakrabarti A (2017) Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis. Mycoses 60(1):33\u201339. https:\/\/doi.org\/10.1111\/myc.12541","journal-title":"Mycoses"},{"key":"8760_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1749-6632.2012.06810.x","volume":"1272","author":"RB Moss","year":"2012","unstructured":"Moss RB (2012) The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Ann N Y Acad Sci 1272:49\u201357. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06810.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8760_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12890-018-0617-5","volume":"18","author":"T Terashima","year":"2018","unstructured":"Terashima T, Shinozaki T, Iwami E, Nakajima T, Matsuzaki T (2018) A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. BMC Pulm Med 18(1):53. https:\/\/doi.org\/10.1186\/s12890-018-0617-5","journal-title":"BMC Pulm Med"},{"issue":"3","key":"8760_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","volume":"130","author":"G Jia","year":"2012","unstructured":"Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma Study G (2012) Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 130(3):647\u2013654 e610. https:\/\/doi.org\/10.1016\/j.jaci.2012.06.025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8760_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/19420862.2017.1392425","volume":"10","author":"M Godar","year":"2018","unstructured":"Godar M, Blanchetot C, de Haard H, Lambrecht BN, Brusselle G (2018) Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. MAbs 10(1):34\u201345. https:\/\/doi.org\/10.1080\/19420862.2017.1392425","journal-title":"MAbs"},{"issue":"13","key":"8760_CR41","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P, Investigators M (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371(13):1198\u20131207. https:\/\/doi.org\/10.1056\/NEJMoa1403290","journal-title":"N Engl J Med"},{"issue":"14","key":"8760_CR42","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.2018.3609","volume":"319","author":"Benralizumab (Fasenra) for Severe Eosinophilic Asthma","year":"2018","unstructured":"Benralizumab (Fasenra) for Severe Eosinophilic Asthma (2018) JAMA 319(14):1501\u20131502. https:\/\/doi.org\/10.1001\/jama.2018.3609","journal-title":"JAMA"},{"issue":"10056","key":"8760_CR43","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkstrom V, Goldman M, investigators Ss (2016) Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388(10056):2115\u20132127. https:\/\/doi.org\/10.1016\/S0140-6736(16)31324-1","journal-title":"Lancet"},{"key":"8760_CR44","doi-asserted-by":"publisher","unstructured":"FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkstrom V, Aurivillius M, Goldman M, investigators Cs (2016) Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 388 (10056):2128\u20132141. doi: https:\/\/doi.org\/10.1016\/S0140-6736(16)31322-8","DOI":"10.1016\/S0140-6736(16)31322-8"},{"issue":"4","key":"8760_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","volume":"150","author":"L Bjermer","year":"2016","unstructured":"Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M (2016) Reslizumab for inadequately controlled Asthma with elevated blood eosinophil levels: a randomized phase 3 study. Chest 150(4):789\u2013798. https:\/\/doi.org\/10.1016\/j.chest.2016.03.032","journal-title":"Chest"},{"issue":"4","key":"8760_CR46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","volume":"150","author":"J Corren","year":"2016","unstructured":"Corren J, Weinstein S, Janka L, Zangrilli J, Garin M (2016) Phase 3 study of Reslizumab in patients with poorly controlled Asthma: effects across a broad range of eosinophil counts. Chest 150(4):799\u2013810. https:\/\/doi.org\/10.1016\/j.chest.2016.03.018","journal-title":"Chest"},{"issue":"26","key":"8760_CR47","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma. N Engl J Med 378(26):2486\u20132496. https:\/\/doi.org\/10.1056\/NEJMoa1804092","journal-title":"N Engl J Med"},{"key":"8760_CR48","unstructured":"Identifier NCT03469934. Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma. National Library of Medicine: ClinicalTrials.gov ."},{"issue":"9","key":"8760_CR49","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/all.12451","volume":"69","author":"R Pettipher","year":"2014","unstructured":"Pettipher R, Hunter MG, Perkins CM, Collins LP, Lewis T, Baillet M, Steiner J, Bell J, Payton MA (2014) Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459. Allergy 69(9):1223\u20131232. https:\/\/doi.org\/10.1111\/all.12451","journal-title":"Allergy"},{"key":"8760_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pupt.2015.03.003","volume":"32","author":"IP Hall","year":"2015","unstructured":"Hall IP, Fowler AV, Gupta A, Tetzlaff K, Nivens MC, Sarno M, Finnigan HA, Bateman ED, Rand Sutherland E (2015) Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. Pulm Pharmacol Ther 32:37\u201344. https:\/\/doi.org\/10.1016\/j.pupt.2015.03.003","journal-title":"Pulm Pharmacol Ther"},{"issue":"S3","key":"8760_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/resp.13207_222","volume":"22","author":"Fevipiprant phase iii exacerbation studies: Luster-1 and luster-2 study design","year":"2017","unstructured":"Fevipiprant phase iii exacerbation studies: Luster-1 and luster-2 study design (2017) Respirology 22(S3):170\u2013170. https:\/\/doi.org\/10.1111\/resp.13207_222","journal-title":"Respirology"},{"issue":"5","key":"8760_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","volume":"374","author":"TM Laidlaw","year":"2016","unstructured":"Laidlaw TM, Boyce JA (2016) Aspirin-exacerbated respiratory disease--new prime suspects. N Engl J Med 374(5):484\u2013488. https:\/\/doi.org\/10.1056\/NEJMcibr1514013","journal-title":"N Engl J Med"},{"issue":"2","key":"8760_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.iac.2012.11.006","volume":"33","author":"TM Laidlaw","year":"2013","unstructured":"Laidlaw TM, Boyce JA (2013) Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin N Am 33(2):195\u2013210. https:\/\/doi.org\/10.1016\/j.iac.2012.11.006","journal-title":"Immunol Allergy Clin N Am"},{"issue":"11","key":"8760_CR54","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJMra1712125","volume":"379","author":"AA White","year":"2018","unstructured":"White AA, Stevenson DD (2018) Aspirin-exacerbated respiratory disease. N Engl J Med 379(11):1060\u20131070. https:\/\/doi.org\/10.1056\/NEJMra1712125","journal-title":"N Engl J Med"},{"issue":"8","key":"8760_CR55","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","volume":"195","author":"T Liu","year":"2015","unstructured":"Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, Buchheit K, Bhattacharya N, Laidlaw TM, Katz HR, Boyce JA (2015) Aspirin-exacerbated respiratory disease involves a Cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway. J Immunol 195(8):3537\u20133545. https:\/\/doi.org\/10.4049\/jimmunol.1500905","journal-title":"J Immunol"},{"key":"8760_CR56","doi-asserted-by":"publisher","first-page":"8160148","DOI":"10.1155\/2017\/8160148","volume":"2017","author":"H Park","year":"2017","unstructured":"Park H, Choi Y, Jung CG, Park HS (2017) Potential biomarkers for NSAID-exacerbated respiratory disease. Mediat Inflamm 2017:8160148\u20138160148. https:\/\/doi.org\/10.1155\/2017\/8160148","journal-title":"Mediat Inflamm"},{"issue":"3","key":"8760_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","volume":"113","author":"MA Kim","year":"2014","unstructured":"Kim MA, Izuhara K, Ohta S, Ono J, Yoon MK, Ban GY, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS (2014) Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 113(3):314\u2013320. https:\/\/doi.org\/10.1016\/j.anai.2014.06.014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"8760_CR58","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00405-016-4273-1","volume":"274","author":"EG Sakalar","year":"2017","unstructured":"Sakalar EG, Muluk NB, Kar M, Cingi C (2017) Aspirin-exacerbated respiratory disease and current treatment modalities. Eur Arch Otorhinolaryngol 274(3):1291\u20131300. https:\/\/doi.org\/10.1007\/s00405-016-4273-1","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4 Pt 1","key":"8760_CR59","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B Dahlen","year":"1998","unstructured":"Dahlen B, Nizankowska E, Szczeklik A, Zetterstrom O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dube LM, Dahlen SE (1998) Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 157(4 Pt 1):1187\u20131194. https:\/\/doi.org\/10.1164\/ajrccm.157.4.9707089","journal-title":"Am J Respir Crit Care Med"},{"key":"8760_CR60","doi-asserted-by":"crossref","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD (2003) Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 111 (1):180\u2013186","DOI":"10.1067\/mai.2003.7"},{"issue":"3","key":"8760_CR61","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaip.2018.01.038","volume":"6","author":"KL Tuttle","year":"2018","unstructured":"Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN (2018) A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 6(3):1045\u20131047. https:\/\/doi.org\/10.1016\/j.jaip.2018.01.038","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8760_CR62","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","volume":"7","author":"SF Weinstein","year":"2018","unstructured":"Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M (2018) Effects of Reslizumab on Asthma outcomes in a subgroup of eosinophilic Asthma patients with self-reported chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 7:589\u2013596.e3. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8760_CR63","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jaip.2016.12.013","volume":"5","author":"E Phillips-Angles","year":"2017","unstructured":"Phillips-Angles E, Barranco P, Lluch-Bernal M, Dominguez-Ortega J, Lopez-Carrasco V, Quirce S (2017) Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab. J Allergy Clin Immunol Pract 5(3):842\u2013845. https:\/\/doi.org\/10.1016\/j.jaip.2016.12.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8760_CR64","doi-asserted-by":"publisher","first-page":"3743048","DOI":"10.1155\/2017\/3743048","volume":"2017","author":"H Gao","year":"2017","unstructured":"Gao H, Ying S, Dai Y (2017) Pathological roles of neutrophil-mediated inflammation in Asthma and its potential for therapy as a target. J Immunol Res 2017:3743048\u20133743012. https:\/\/doi.org\/10.1155\/2017\/3743048","journal-title":"J Immunol Res"},{"issue":"11","key":"8760_CR65","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbagen.2011.02.002","volume":"1810","author":"SJ Aujla","year":"2011","unstructured":"Aujla SJ, Alcorn JF (2011) T(H)17 cells in asthma and inflammation. Biochim Biophys Acta 1810(11):1066\u20131079. https:\/\/doi.org\/10.1016\/j.bbagen.2011.02.002","journal-title":"Biochim Biophys Acta"},{"key":"8760_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-pathol-012414-040343","volume":"10","author":"HE Trejo Bittar","year":"2015","unstructured":"Trejo Bittar HE, Yousem SA, Wenzel SE (2015) Pathobiology of severe asthma. Annu Rev Pathol 10:511\u2013545. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040343","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"8760_CR67","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","volume":"123","author":"W Al-Ramli","year":"2009","unstructured":"Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, Hamid Q (2009) T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 123(5):1185\u20131187. https:\/\/doi.org\/10.1016\/j.jaci.2009.02.024","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8760_CR68","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.imbio.2014.09.016","volume":"220","author":"H Vroman","year":"2015","unstructured":"Vroman H, van den Blink B, Kool M (2015) Mode of dendritic cell activation: the decisive hand in Th2\/Th17 cell differentiation. Implications in asthma severity? Immunobiology 220(2):254\u2013261. https:\/\/doi.org\/10.1016\/j.imbio.2014.09.016","journal-title":"Immunobiology"},{"issue":"1","key":"8760_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1183\/09031936.02.00226302","volume":"19","author":"PA Wark","year":"2002","unstructured":"Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG (2002) Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19(1):68\u201375","journal-title":"Eur Respir J"},{"issue":"1","key":"8760_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1586\/17476348.2014.854167","volume":"8","author":"ML Manni","year":"2014","unstructured":"Manni ML, Robinson KM, Alcorn JF (2014) A tale of two cytokines: IL-17 and IL-22 in asthma and infection. Expert Rev Respir Med 8(1):25\u201342. https:\/\/doi.org\/10.1586\/17476348.2014.854167","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"8760_CR71","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jaci.2014.02.015","volume":"133","author":"S Yu","year":"2014","unstructured":"Yu S, Kim HY, Chang YJ, DeKruyff RH, Umetsu DT (2014) Innate lymphoid cells and asthma. J Allergy Clin Immunol 133(4):943\u2013950; quiz 951. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.015","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8760_CR72","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1189\/jlb.3VMR1214-600RR","volume":"98","author":"PL Bruijnzeel","year":"2015","unstructured":"Bruijnzeel PL, Uddin M, Koenderman L (2015) Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype? J Leukoc Biol 98(4):549\u2013556. https:\/\/doi.org\/10.1189\/jlb.3VMR1214-600RR","journal-title":"J Leukoc Biol"},{"issue":"4\u20135","key":"8760_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3109\/08820131003615498","volume":"39","author":"DM Durrant","year":"2010","unstructured":"Durrant DM, Metzger DW (2010) Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Investig 39(4\u20135):526\u2013549. https:\/\/doi.org\/10.3109\/08820131003615498","journal-title":"Immunol Investig"},{"issue":"2","key":"8760_CR74","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1378\/chest.12-0598","volume":"143","author":"R Halwani","year":"2013","unstructured":"Halwani R, Al-Muhsen S, Hamid Q (2013) T helper 17 cells in airway diseases: from laboratory bench to bedside. Chest 143(2):494\u2013501. https:\/\/doi.org\/10.1378\/chest.12-0598","journal-title":"Chest"},{"issue":"5","key":"8760_CR75","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11882-011-0210-y","volume":"11","author":"YH Wang","year":"2011","unstructured":"Wang YH, Wills-Karp M (2011) The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep 11(5):388\u2013394. https:\/\/doi.org\/10.1007\/s11882-011-0210-y","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"8760_CR76","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/IAI.72.7.3823-3828.2004","volume":"72","author":"V Asensi","year":"2004","unstructured":"Asensi V, Valle E, Meana A, Fierer J, Celada A, Alvarez V, Paz J, Coto E, Carton JA, Maradona JA, Dieguez A, Sarasua J, Ocana MG, Arribas JM (2004) In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect Immun 72(7):3823\u20133828. https:\/\/doi.org\/10.1128\/IAI.72.7.3823-3828.2004","journal-title":"Infect Immun"},{"issue":"7","key":"8760_CR77","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1161\/01.CIR.92.7.1866","volume":"92","author":"GL Kukielka","year":"1995","unstructured":"Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML (1995) Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92(7):1866\u20131875","journal-title":"Circulation"},{"issue":"6","key":"8760_CR78","doi-asserted-by":"publisher","first-page":"H2954","DOI":"10.1152\/ajpheart.2000.279.6.H2954","volume":"279","author":"T Suwa","year":"2000","unstructured":"Suwa T, Hogg JC, English D, Van Eeden SF (2000) Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow. Am J Physiol Heart Circ Physiol 279(6):H2954\u2013H2960. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.6.H2954","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"8760_CR79","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/thoraxjnl-2014-206067","volume":"70","author":"AT Essilfie","year":"2015","unstructured":"Essilfie AT, Horvat JC, Kim RY, Mayall JR, Pinkerton JW, Beckett EL, Starkey MR, Simpson JL, Foster PS, Gibson PG, Hansbro PM (2015) Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax 70(5):458\u2013467. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206067","journal-title":"Thorax"},{"issue":"2","key":"8760_CR80","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","volume":"177","author":"JL Simpson","year":"2008","unstructured":"Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177(2):148\u2013155. https:\/\/doi.org\/10.1164\/rccm.200707-1134OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8760_CR81","unstructured":"Identifier NCT03532490. Trial of Roflumilast in Asthma Management (TRIM). National Library of Medicine: ClinicalTrials.gov ."},{"issue":"11","key":"8760_CR82","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, Lin SL (2013) Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 188(11):1294\u20131302. https:\/\/doi.org\/10.1164\/rccm.201212-2318OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8760_CR83","unstructured":"Identifier NCT03299686. Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma. National Library of Medicine: ClinicalTrials.gov ."},{"issue":"5","key":"8760_CR84","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jaci.2008.03.004","volume":"121","author":"SA Shore","year":"2008","unstructured":"Shore SA (2008) Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 121(5):1087\u20131093; quiz 1094-1085. https:\/\/doi.org\/10.1016\/j.jaci.2008.03.004","journal-title":"J Allergy Clin Immunol"},{"key":"8760_CR85","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1152\/jappl.1960.15.3.377","volume":"15","author":"A Naimark","year":"1960","unstructured":"Naimark A, Cherniack RM (1960) Compliance of the respiratory system and its components in health and obesity. J Appl Physiol 15:377\u2013382. https:\/\/doi.org\/10.1152\/jappl.1960.15.3.377","journal-title":"J Appl Physiol"},{"issue":"6","key":"8760_CR86","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00421-006-0389-0","volume":"99","author":"J Milic-Emili","year":"2007","unstructured":"Milic-Emili J, Torchio R, D'Angelo E (2007) Closing volume: a reappraisal (1967-2007). Eur J Appl Physiol 99(6):567\u2013583. https:\/\/doi.org\/10.1007\/s00421-006-0389-0","journal-title":"Eur J Appl Physiol"},{"issue":"11","key":"8760_CR87","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.bbagen.2011.09.004","volume":"1810","author":"NL Lugogo","year":"2011","unstructured":"Lugogo NL, Bappanad D, Kraft M (2011) Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta 1810(11):1120\u20131126. https:\/\/doi.org\/10.1016\/j.bbagen.2011.09.004","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"8760_CR88","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1398-9995.2008.01872.x","volume":"64","author":"T Jartti","year":"2009","unstructured":"Jartti T, Saarikoski L, Jartti L, Lisinen I, Jula A, Huupponen R, Viikari J, Raitakari OT (2009) Obesity, adipokines and asthma. Allergy 64(5):770\u2013777. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01872.x","journal-title":"Allergy"},{"issue":"5","key":"8760_CR89","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11882-013-0354-z","volume":"13","author":"S Pradeepan","year":"2013","unstructured":"Pradeepan S, Garrison G, Dixon AE (2013) Obesity in asthma: approaches to treatment. Curr Allergy Asthma Rep 13(5):434\u2013442. https:\/\/doi.org\/10.1007\/s11882-013-0354-z","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"8760_CR90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cea.12004","volume":"43","author":"HA Scott","year":"2013","unstructured":"Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ, Callister R, Wood LG (2013) Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy 43(1):36\u201349. https:\/\/doi.org\/10.1111\/cea.12004","journal-title":"Clin Exp Allergy"},{"key":"8760_CR91","doi-asserted-by":"publisher","unstructured":"Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, Garudathri J, Raymond D, Poynter ME, Bunn JY, Irvin CG (2011) Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J allergy Clin Immunol 128 (3):508-515 e501-502. https:\/\/doi.org\/10.1016\/j.jaci.2011.06.009","DOI":"10.1016\/j.jaci.2011.06.009"},{"issue":"5","key":"8760_CR92","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.anai.2017.09.072","volume":"119","author":"H Ortega","year":"2017","unstructured":"Ortega H, Albers F, Llanos-Ackert J, Bradford E, Price R, Pouliquen I, Castro M (2017) P506 impact of weight on the efficacy of mepolizumab in patients with severe eosinophilic asthma. Ann Allergy Asthma Immunol 119(5):e3\u2013e4. https:\/\/doi.org\/10.1016\/j.anai.2017.09.072","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8760_CR93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40733-015-0004-4","volume":"1","author":"M Bonini","year":"2015","unstructured":"Bonini M, Palange P (2015) Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment. Asthma Res Pract 1:2. https:\/\/doi.org\/10.1186\/s40733-015-0004-4","journal-title":"Asthma Res Pract"},{"issue":"3","key":"8760_CR94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1067\/mai.2000.109822","volume":"106","author":"SD Anderson","year":"2000","unstructured":"Anderson SD, Daviskas E (2000) The mechanism of exercise-induced asthma is. J Allergy Clin Immunol 106(3):453\u2013459. https:\/\/doi.org\/10.1067\/mai.2000.109822","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8760_CR95","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1164\/rccm.200412-1667OC","volume":"172","author":"TS Hallstrand","year":"2005","unstructured":"Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr, Aitken ML (2005) Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 172(6):679\u2013686. https:\/\/doi.org\/10.1164\/rccm.200412-1667OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"8760_CR96","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaci.2008.05.001","volume":"122","author":"SD Anderson","year":"2008","unstructured":"Anderson SD, Kippelen P (2008) Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol 122(2):225\u2013235; quiz 236-227. https:\/\/doi.org\/10.1016\/j.jaci.2008.05.001","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Pt 1","key":"8760_CR97","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/ajrccm.162.3.9911099","volume":"162","author":"S Hashimoto","year":"2000","unstructured":"Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Maruoka S, Horie T (2000) Inhalant corticosteroids inhibit hyperosmolarity-induced, and cooling and rewarming-induced interleukin-8 and RANTES production by human bronchial epithelial cells. Am J Respir Crit Care Med 162(3 Pt 1):1075\u20131080. https:\/\/doi.org\/10.1164\/ajrccm.162.3.9911099","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8760_CR98","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1566-0702(02)00268-0","volume":"104","author":"JA Filipe","year":"2003","unstructured":"Filipe JA, Falcao-Reis F, Castro-Correia J, Barros H (2003) Assessment of autonomic function in high level athletes by pupillometry. Auton Neurosci 104(1):66\u201372","journal-title":"Auton Neurosci"},{"issue":"1","key":"8760_CR99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1378\/chest.122.1.166","volume":"122","author":"H Kanazawa","year":"2002","unstructured":"Kanazawa H, Asai K, Hirata K, Yoshikawa J (2002) Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 122(1):166\u2013170","journal-title":"Chest"},{"issue":"2","key":"8760_CR100","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/rmed.2001.1238","volume":"96","author":"YI Koh","year":"2002","unstructured":"Koh YI, Choi S (2002) Blood eosinophil counts for the prediction of the severity of exercise-induced bronchospasm in asthma. Respir Med 96(2):120\u2013125","journal-title":"Respir Med"},{"issue":"4","key":"8760_CR101","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1378\/chest.128.4.1964","volume":"128","author":"F Buchvald","year":"2005","unstructured":"Buchvald F, Hermansen MN, Nielsen KG, Bisgaard H (2005) Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children. Chest 128(4):1964\u20131967. https:\/\/doi.org\/10.1378\/chest.128.4.1964","journal-title":"Chest"},{"issue":"1","key":"8760_CR102","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1378\/chest.08-0722","volume":"135","author":"M Barreto","year":"2009","unstructured":"Barreto M, Villa MP, Olita C, Martella S, Ciabattoni G, Montuschi P (2009) 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest 135(1):66\u201373. https:\/\/doi.org\/10.1378\/chest.08-0722","journal-title":"Chest"},{"issue":"8","key":"8760_CR103","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1164\/ajrccm.165.8.200111-091bc","volume":"165","author":"RJ Hancox","year":"2002","unstructured":"Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD (2002) Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 165(8):1068\u20131070. https:\/\/doi.org\/10.1164\/ajrccm.165.8.200111-091bc","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"8760_CR104","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJM199807163390302","volume":"339","author":"JA Leff","year":"1998","unstructured":"Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF (1998) Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 339(3):147\u2013152. https:\/\/doi.org\/10.1056\/NEJM199807163390302","journal-title":"N Engl J Med"},{"issue":"2","key":"8760_CR105","first-page":"97","volume":"132","author":"JM Edelman","year":"2000","unstructured":"Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS (2000) Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group Ann Intern Med 132(2):97\u2013104","journal-title":"Exercise Study Group Ann Intern Med"},{"key":"8760_CR106","unstructured":"IdentifierNCT03327701 The Effect of Benralizumab on Exercise-induced Bronchoconstriction. National Library of Medicine: ClinicalTrials.gov ."},{"issue":"6740","key":"8760_CR107","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/bmj.300.6740.1602","volume":"300","author":"JG Ayres","year":"1990","unstructured":"Ayres JG (1990) Late onset asthma. BMJ 300(6740):1602\u20131603","journal-title":"BMJ"},{"key":"8760_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/JAA.S125948","volume":"11","author":"T Hirano","year":"2018","unstructured":"Hirano T, Matsunaga K (2018) Late-onset asthma: current perspectives. J Asthma Allergy 11:19\u201327. https:\/\/doi.org\/10.2147\/JAA.S125948","journal-title":"J Asthma Allergy"},{"issue":"127","key":"8760_CR109","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1183\/09059180.00007112","volume":"22","author":"SB de Nijs","year":"2013","unstructured":"de Nijs SB, Venekamp LN, Bel EH (2013) Adult-onset asthma: is it really different? Eur Respir Rev 22(127):44\u201352. https:\/\/doi.org\/10.1183\/09059180.00007112","journal-title":"Eur Respir Rev"},{"issue":"2","key":"8760_CR110","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/all.13258","volume":"73","author":"RM Dunn","year":"2018","unstructured":"Dunn RM, Busse PJ, Wechsler ME (2018) Asthma in the elderly and late-onset adult asthma. Allergy 73(2):284\u2013294. https:\/\/doi.org\/10.1111\/all.13258","journal-title":"Allergy"},{"key":"8760_CR111","doi-asserted-by":"publisher","first-page":"514868","DOI":"10.1155\/2015\/514868","volume":"2015","author":"P Ilmarinen","year":"2015","unstructured":"Ilmarinen P, Tuomisto LE, Kankaanranta H (2015) Phenotypes, risk factors, and mechanisms of adult-onset Asthma. Mediat Inflamm 2015:514868\u2013514819. https:\/\/doi.org\/10.1155\/2015\/514868","journal-title":"Mediat Inflamm"},{"issue":"9347","key":"8760_CR112","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","volume":"360","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID (2002) Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360(9347):1715\u20131721. https:\/\/doi.org\/10.1016\/S0140-6736(02)11679-5","journal-title":"Lancet"},{"issue":"3","key":"8760_CR113","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178(3):218\u2013224. https:\/\/doi.org\/10.1164\/rccm.200711-1754OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"8760_CR114","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1067\/mai.2003.1487","volume":"111","author":"A Szczeklik","year":"2003","unstructured":"Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111(5):913\u2013921 quiz 922","journal-title":"J Allergy Clin Immunol"},{"key":"8760_CR115","doi-asserted-by":"publisher","unstructured":"van Veen IH, Ten Brinke A, Gauw SA, Sterk PJ, Rabe KF, Bel EH (2009) Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J allergy Clin Immunol 124 (3):615-617, 617 e611-612. doi: https:\/\/doi.org\/10.1016\/j.jaci.2009.06.029","DOI":"10.1016\/j.jaci.2009.06.029"},{"issue":"6","key":"8760_CR116","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1183\/09031936.00100811","volume":"41","author":"TB Kim","year":"2013","unstructured":"Kim TB, Jang AS, Kwon HS, Park JS, Chang YS, Cho SH, Choi BW, Park JW, Nam DH, Yoon HJ, Cho YJ, Moon HB, Cho YS, Park CS, Group CS (2013) Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 41(6):1308\u20131314. https:\/\/doi.org\/10.1183\/09031936.00100811","journal-title":"Eur Respir J"},{"issue":"12","key":"8760_CR117","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365(12):1088\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa1106469","journal-title":"N Engl J Med"},{"issue":"2","key":"8760_CR118","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1164\/rccm.200903-0354OC","volume":"181","author":"M Castro","year":"2010","unstructured":"Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade LM, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Duhamel DR, McEvoy C, Barbers R, Ten Hacken NH, Wechsler ME, Holmes M, Phillips MJ, Erzurum S, Lunn W, Israel E, Jarjour N, Kraft M, Shargill NS, Quiring J, Berry SM, Cox G, Group AIRTS (2010) Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 181(2):116\u2013124. https:\/\/doi.org\/10.1164\/rccm.200903-0354OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"8760_CR119","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.200507-1162OC","volume":"173","author":"G Cox","year":"2006","unstructured":"Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S (2006) Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 173(9):965\u2013969. https:\/\/doi.org\/10.1164\/rccm.200507-1162OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"8760_CR120","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa064707","volume":"356","author":"G Cox","year":"2007","unstructured":"Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, Mccormack D, Chaudhuri R, Miller JD, Laviolette M, Group AIRTS (2007) Asthma control during the year after bronchial thermoplasty. N Engl J Med 356(13):1327\u20131337. https:\/\/doi.org\/10.1056\/NEJMoa064707","journal-title":"N Engl J Med"},{"issue":"4","key":"8760_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","volume":"181","author":"WC Moore","year":"2010","unstructured":"Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D\u2019Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER, National Heart L, Blood Institute's Severe Asthma Research P (2010) Identification of asthma phenotypes using cluster analysis in the severe Asthma research program. Am J Respir Crit Care Med 181(4):315\u2013323. https:\/\/doi.org\/10.1164\/rccm.200906-0896OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8760_CR122","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jaci.2013.10.006","volume":"133","author":"M Schatz","year":"2014","unstructured":"Schatz M, Hsu JW, Zeiger RS, Chen W, Dorenbaum A, Chipps BE, Haselkorn T (2014) Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol 133(6):1549\u20131556. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.006","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-019-08760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T17:09:24Z","timestamp":1695056964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-019-08760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["8760"],"URL":"https:\/\/doi.org\/10.1007\/s12016-019-08760-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"29 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}